Cargando…
Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Controlled Human Infection Models (CHIMs) involve deliberately exposing healthy human volunteers to a known pathogen, to allow the detailed study of disease processes and evaluate methods of treatment and prevention, including next generation vaccines. CHIMs are in development for both tuberculosis...
Autores principales: | Morrison, Hazel, Jackson, Susan, McShane, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248465/ https://www.ncbi.nlm.nih.gov/pubmed/37304270 http://dx.doi.org/10.3389/fimmu.2023.1211388 |
Ejemplares similares
-
Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021) -
Controlled Human Infection Models: Is it Really Feasible to Give People Tuberculosis?
por: McShane, Helen
Publicado: (2020) -
Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
por: Stylianou, Elena, et al.
Publicado: (2019) -
Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014) -
Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)